JP2012500194A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500194A5
JP2012500194A5 JP2011522551A JP2011522551A JP2012500194A5 JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5 JP 2011522551 A JP2011522551 A JP 2011522551A JP 2011522551 A JP2011522551 A JP 2011522551A JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5
Authority
JP
Japan
Prior art keywords
polypeptide
protein
peptide
allergen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500194A (ja
JP5705113B2 (ja
Filing date
Publication date
Priority claimed from PCT/GB2008/002781 external-priority patent/WO2009022157A2/en
Priority claimed from GB0814986A external-priority patent/GB0814986D0/en
Priority claimed from GB0815218A external-priority patent/GB0815218D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from EP09251252.4A external-priority patent/EP2153841B2/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Publication of JP2012500194A publication Critical patent/JP2012500194A/ja
Publication of JP2012500194A5 publication Critical patent/JP2012500194A5/ja
Publication of JP5705113B2 publication Critical patent/JP5705113B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522551A 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原 Expired - Fee Related JP5705113B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
GB0814986.6 2008-08-15
GBPCT/GB08/002780 2008-08-15
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
GB0814986A GB0814986D0 (en) 2008-08-15 2008-08-15 Peptide for il10 production
GBPCT/GB08/002781 2008-08-15
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
GBPCT/GB08/002779 2008-08-15
GBPCT/GB08/002778 2008-08-15
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
GB0815218A GB0815218D0 (en) 2008-08-20 2008-08-20 Ragweed peptides for vaccine
GB0815218.3 2008-08-20
GB0901927.4 2009-02-05
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
EP09251252.4A EP2153841B2 (en) 2008-08-15 2009-05-01 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
EP09251252.4 2009-05-01
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
GB0912578.2 2009-07-20
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production

Publications (3)

Publication Number Publication Date
JP2012500194A JP2012500194A (ja) 2012-01-05
JP2012500194A5 true JP2012500194A5 (cg-RX-API-DMAC7.html) 2012-10-04
JP5705113B2 JP5705113B2 (ja) 2015-04-22

Family

ID=41112622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522551A Expired - Fee Related JP5705113B2 (ja) 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原

Country Status (4)

Country Link
US (2) US8821887B2 (cg-RX-API-DMAC7.html)
EP (1) EP2331124A1 (cg-RX-API-DMAC7.html)
JP (1) JP5705113B2 (cg-RX-API-DMAC7.html)
WO (1) WO2010018384A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1008802A2 (pt) 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
CN118078979A (zh) 2011-04-29 2024-05-28 西莱克塔生物科技公司 用于降低针对治疗性蛋白的免疫应答的致耐受性合成纳米载体
CA2843274A1 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
GB201209862D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
DK2914286T3 (da) 2012-10-30 2021-11-08 Aravax Pty Ltd Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf
US10434088B2 (en) 2013-05-03 2019-10-08 Selecta Biosciences, Inc. Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
JP7007534B2 (ja) 2013-09-25 2022-01-24 アラヴァックス ピーティーワイ リミテッド 新規免疫療法組成物およびその使用
AU2014369866A1 (en) 2013-12-23 2016-06-30 Alk-Abello A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2016037165A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
JPWO2016159181A1 (ja) * 2015-03-30 2018-02-22 国立大学法人大阪大学 免疫用ペプチド、免疫用ペプチドの製造方法、それを含む免疫疾患用医薬組成物、および免疫疾患の治療方法
CA3055936A1 (en) 2017-03-11 2018-09-20 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
EP4047007B1 (en) * 2019-10-18 2024-06-05 Pell Bio-Med Technology Co., Ltd. Peptide and use thereof in preparation of drug for treating inflammatory diseases and pain

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032868D1 (de) 1989-03-17 1999-02-11 Immulogic Pharma Corp Allergene proteine aus ambrosia und verwendung davon
US5776761A (en) 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
DE69131131T2 (de) * 1990-09-11 1999-10-14 Institute For Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
ES2334179T3 (es) * 1991-10-16 2010-03-05 Merck Patent Gmbh Epitopes de celulas t de los alergenos principales de dermatofagoides (acaros del polvo domestico).
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
JPH07507924A (ja) 1992-04-09 1995-09-07 イミュロジック　ファーマスーティカル　コーポレイション アンブロシア・アルテミシフォリア由来の主要アレルゲンのｔ細胞エピトープ
JPH09501043A (ja) * 1993-04-14 1997-02-04 イミュロジク ファーマスーティカル コーポレイション Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ（室内塵ダニ）由来の主要アレルゲンのｔ細胞エピトープ
ATE359296T1 (de) * 1994-04-14 2007-05-15 Merck Patent Gmbh Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US7112333B1 (en) 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
WO1996013589A1 (en) 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
EP1044019A1 (en) * 1998-01-09 2000-10-18 Circassia Limited Methods and compositions for desensitisation
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
GB0108752D0 (en) 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
DE60229979D1 (cg-RX-API-DMAC7.html) 2001-12-05 2009-01-02 Circassia Ltd
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
EP1899367A4 (en) 2005-06-10 2009-06-24 Univ Singapore Mutant allergen(s)
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
EP1958645A1 (en) 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
ES2425486T3 (es) 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022155A2 (en) 2007-08-15 2009-02-19 Circassia Limited Peptide with reduced dimer formation
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
DK2153841T4 (en) * 2008-08-15 2016-02-15 Circassia Ltd Vaccine comprising Amb a 1 peptides for use in the treatment of ambrosieallergi

Similar Documents

Publication Publication Date Title
JP2012500194A5 (cg-RX-API-DMAC7.html)
CN102227214B (zh) 二聚体形成减少的组合物
JP5755398B2 (ja) 伸長されたｇｌｐ−１化合物
ES2532116T3 (es) Péptidos derivados con A-B-C-D y sus usos terapéuticos
US20230073594A1 (en) Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases
Windeløv et al. Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
Virtanen et al. Mammalian lipocalin allergens–insights into their enigmatic allergenicity
JP5209463B2 (ja) アシル化ｇｌｐ−１化合物
US8580918B2 (en) Peptidic GLP-2 agonists
JP2010536333A5 (cg-RX-API-DMAC7.html)
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
HRP20130270T1 (hr) Peptid s reduciranom formacijom dimera
US20190070287A1 (en) Tolerance therapeutic for treating polypeptide induced immune activation
KR20110017874A (ko) 오래 작용하는 ｙ２ 및／또는 ｙ４ 수용체 작용제
US20150141336A1 (en) Pancreatic Peptide Compounds and Use
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
RS57152B1 (sr) Mimetici kalcitonina za lečenje bolesti i poremećaja
JP2012516693A5 (cg-RX-API-DMAC7.html)
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
EP3393498A1 (en) Encapsulation of ultra-stable insulin analogues with polymer melts
EP4615499A1 (en) Vaccine for treating allergies
FR2744123A1 (fr) Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance
US20250388638A1 (en) Compositions and methods for oral delivery
JP2007512812A (ja) 羊膜由来ペプチドおよびその使用
AU2015227499A1 (en) Compositions with reduced dimer formation